Category

Australia

Daily Brief Australia: Airtasker, Iron Ore and more

By | Australia, Daily Briefs

In today’s briefing:

  • Airtasker Ltd – Media deals drive positive revenue trends
  • Iron Ore Tracker (04-Mar-2025): PMI Rebound And China TSF Looking Good, All Eyes On NPC


Airtasker Ltd – Media deals drive positive revenue trends

By Research as a Service (RaaS)

  • Airtasker Limited (ASX:ART) is an online marketplace for local services, connecting people and businesses who need work done with people who want to work.
  • ART’s reported H1 FY25 results are messy, with a number of non-cash items including media capital spend distorting reported numbers.
  • On an adjusted basis revenue growth was 11%, with Airtasker marketplace growth closer to 15%.

Iron Ore Tracker (04-Mar-2025): PMI Rebound And China TSF Looking Good, All Eyes On NPC

By Sameer Taneja

  • The Trump administration’s announcement of a 60% tariff on Chinese steel imports affected the market sentiment, leading to a 3% decline in iron ore prices last week.
  • China’s Manufacturing PMI rose to 50.2 in February, surpassing the expected 49.9, while the record Total Social Financing in January also contributed significantly to this positive outlook.
  • Iron ore prices can remain rangebound (95-110 USD/ton), with the positive demand-side catalysts from China outweighing the long-term supply fears from Rio’s Simandou project. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Kinatico and more

By | Australia, Daily Briefs

In today’s briefing:

  • Kinatico Interview Transcript post H1 FY25 result
  • Kinatico Ltd – HIgher-margin SaaS revenue, flat costs propel EBITDA


Kinatico Interview Transcript post H1 FY25 result

By Research as a Service (RaaS)

  • Kinatico Ltd (ASX:KYP) is a ‘Know Your People’ regtech company providing workforce compliance monitoring and management technology and services.
  • RaaS Research Group interviewed CEO Michael Ivanchenko post the H1 FY25 results.

Kinatico Ltd – HIgher-margin SaaS revenue, flat costs propel EBITDA

By Research as a Service (RaaS)

  • Kinatico Ltd (ASX:KYP) is a ‘Know Your People’ regtech company providing workforce compliance monitoring and management technology and services.
  • The company has reported H1 FY25 adjusted EBITDA of $2.3m, up 17% on the previous corresponding period (pcp) and 10% ahead of our forecast.
  • Reported EBITDA was $2.1m, up 9% on the pcp.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Lynas Corp Ltd, Mesoblast Ltd, Auric Mining, Barton Gold Holdings , Pureprofile Ltd, Vertex Minerals and more

By | Australia, Daily Briefs

In today’s briefing:

  • Will depressed prices force a Lynas raising?
  • Mesoblast (MSB AU): ‘Comparable’ Pricing for Ryoncil; US Commercialization Is Progressing
  • Auric Mining Limited – Turning Gold into Cash Flow
  • Barton Gold Holdings Limited – Building Towards Being the Next Producer in SA
  • Pureprofile Ltd – H1 FY25 outpaces RaaS forecasts and pcp
  • Vertex Minerals Limited – Building Towards Production


Will depressed prices force a Lynas raising?

By Money of Mine

  • Lynas, a six and a half billion dollar mining company, faced challenges in their half yearly results with higher unit costs and a significant decrease in cash position.
  • The company’s cash reserves have diminished by over $200 million, raising concerns about the sustainability of their operations in the current rare earths price environment.
  • Expansion projects in Mount Weld and Kalgoorlie are ongoing, with potential impacts on future financial performance and the need for additional financing options.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Mesoblast (MSB AU): ‘Comparable’ Pricing for Ryoncil; US Commercialization Is Progressing

By Tina Banerjee

  • Mesoblast Ltd (MSB AU) has announced pricing for Ryoncil in the U.S. in tandem with the economic value of treatment with product availability planned for the current quarter.
  • Wholesale acquisition cost of Ryoncil has been set at $194K per infusion. Ryoncil infusion is given twice per week for 4 weeks. This brings the full treatment cost to $1.55M.
  • The pricing is strategically determined against the cost of treating a child who dies of SR-aGvHD of $2.5M and calculated total benefits of patient outcomes using Ryoncil of $3.2–4.1M.

Auric Mining Limited – Turning Gold into Cash Flow

By Research as a Service (RaaS)

  • Auric Mining Limited (ASX:AWJ) is a junior gold company aiming to take advantage of higher gold prices to generate cash flow from two key projects.
  • AWJ has been mining and tolling ore from the Jeffreys Find Project since late 2023 and has generated ~$105m in revenue from the production and sale of 27.6koz of gold.
  • To date, AWJ has received ~$12.9m in net proceeds from the project with further distributions to be received in 2H25.

Barton Gold Holdings Limited – Building Towards Being the Next Producer in SA

By Research as a Service (RaaS)

  • Barton Gold Holdings Limited (ASX:BGD) is a junior gold company that is focused on progressing the development of the Tunkillia project after completing a scoping study in July 24.
  • The study highlighted the potential for an economic mining operation which would produce 833koz of gold and 1,993koz of silver over ~six years.
  • In addition to continuing development work, BGD continues to conduct exploration at Tunkillia and its Tarcoola project.

Pureprofile Ltd – H1 FY25 outpaces RaaS forecasts and pcp

By Research as a Service (RaaS)

  • Pureprofile Ltd (ASX:PPL) is a data analytics and consumer insights company underpinned by proprietary technology, servicing business decision makers in brands and media companies as well as market researchers.
  • Pureprofile has reported audited H1 FY25 results substantially ahead of the previous corresponding period (pcp) and our forecasts.
  • Revenue increased 23% to $29.7m, gross profit rose 25% to $16.3m and delivered a 55% margin, underlying EBITDA increased 39% to $3.3m and underlying NPAT jumped 139% to $1.8m, a record result for the company.

Vertex Minerals Limited – Building Towards Production

By Research as a Service (RaaS)

  • Vertex Minerals Limited (ASX:VTX) is a junior gold company which is in the process of restarting mining operations at the Reward Gold Mine in NSW in order to take advantage of higher gold prices.
  • With the restart underway, CY25 is set to be the year that the company can show regular production and cash-flow generation from the mine.
  • Commissioning is underway with stockpiles to be processed first ahead of the ramp-up in underground mining which should provide the plant with fresh high-grade ore later in the year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Equinox Resources Ltd, Guzman Y Gomez, Mesoblast Ltd, SelfWealth Ltd, Global Traffic Network, Amaero International Ltd, WRKR and more

By | Australia, Daily Briefs

In today’s briefing:

  • Will this miner crack a commodity monopoly?
  • Guzman IPO Lockup – Pop Done, Correction Ongoing, Now Time for the Lockup
  • ASX200 Index AdHoc Rebalance Preview: Mesoblast (MSB) Could Replace Arcadium Lithium (LTM) Next Week
  • SelfWealth (SWF AU) Enters Into Scheme With Svava
  • GTN Ltd – Canada and costs set to drive accelerated growth in H2
  • Amaero International Ltd – Fully funded through to commercialisation
  • WRKR Ltd – H1 FY25 metrics in-line


Will this miner crack a commodity monopoly?

By Money of Mine

  • Equinox and Calibre announced a deal that was met with mixed reactions, with shareholders on both sides expressing dissatisfaction.
  • The deal, which includes Equinox acquiring Calibre in an all-script deal, has led to a 7% drop in Calibre’s share price.
  • The deal will result in a combined group with nine producing mines and a mine under construction, with a pro forma ownership of 65% Equinox and 35% Calibre.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Guzman IPO Lockup – Pop Done, Correction Ongoing, Now Time for the Lockup

By Sumeet Singh

  • Guzman Y Gomez (GYG AU) raised around US$221m in its Australian IPO. Its IPO linked partial lockup expiry is due soon.
  • GYG is a quick service restaurant business with more than 200 restaurants globally. It mainly focuses on fresh, made-to-order, Mexican-inspired food.
  • In this note, we will talk about the lockup dynamics and possible placement.

ASX200 Index AdHoc Rebalance Preview: Mesoblast (MSB) Could Replace Arcadium Lithium (LTM) Next Week

By Brian Freitas


SelfWealth (SWF AU) Enters Into Scheme With Svava

By David Blennerhassett

  • After online trading player SelfWealth (SWF AU) entered into a SID with Bell Financial (BFG AU) on the 25th November, Singaporean-based wealth manager Svava gate-crashed the party earlier this month. 
  • Svava tabled a non-binding A$0.28/share Offer, in cash, by way of a Scheme, versus Bell’s A$0.25/share. Svava also built an effective blocking stake – 18.83% of shares out.
  • After Bell said it won’t make a counterproposal yesterday, SelfWealth has now entered into Scheme with Svava. Expect implementation in May. 

GTN Ltd – Canada and costs set to drive accelerated growth in H2

By Research as a Service (RaaS)

  • RaaS has published an update on media group GTN Ltd following its H1 FY25 results in which it reported an 11% increase in adjusted EPS to $0.034.
  • NPAT was 10% below our estimates, although normalising for additional Australian inventory spots and non-recurring costs, it was closer to our estimates.
  • The H1 dividend was higher than we expected with 100% of NPATA paid out versus prior policy of 50% payout.

Amaero International Ltd – Fully funded through to commercialisation

By Research as a Service (RaaS)

  • RaaS Research Group has published an update on advanced materials manufacturing group Amaero International (ASX:3DA) following recent events including execution of the credit agreement for the US$22.8m loan from the Export-Import Bank of the United States, the $22m institutional share placement and release of the H1 FY25 results.The company recently announced a $22m institutional placement, priced at $0.30/share, concluding a series of six strategic capital raises since May 2022 to raise $98.5m.
  • The company says the proceeds from the raise together with the now executed credit agreement for a US$22.8m (A$36.2m) loan from the Export-Import Bank of the United States (EXIM), will fund Amaero’s planned capital expenditure and operations through to anticipated EBITDA break-even in FY26.
  • Separately, Amaero has also released its H1 FY25 accounts, delivering a better-than-forecast underlying EBITDA loss of $7.5m versus our forecast for $9.1m.

WRKR Ltd – H1 FY25 metrics in-line

By Research as a Service (RaaS)

  • RaaS has published an update on superannuation and payroll compliance solutions business Wrkr (ASX:WRK) following its H1 FY25 results in which it delivered a result in line with our expectations and an improvement on H1 FY24.
  • Revenue growth was 26%, aided by higher float interest income and project work, while costs were well maintained, rising 13% on the back of higher staff costs (new hires in readiness for client onboarding).
  • RaaS adjusted EBITDA was -$0.13m, in-line with forecasts and lower than the -$0.5m in H1 FY24.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Pointerra Ltd, PointsBet Holdings and more

By | Australia, Daily Briefs

In today’s briefing:

  • Pointerra Ltd – Back in the black, H1 FY25 forecasts beat
  • PointsBet (PBH AU) Rebuffs BlueBet And Enters Offer With Mixi (2121 JP)


Pointerra Ltd – Back in the black, H1 FY25 forecasts beat

By Research as a Service (RaaS)

  • RaaS has published an update on 3D spatial data solutions group Pointerra (ASX:3DP) following the release of its H1 FY25 results in which the company returned to profitability, reporting underlying NPAT of $1.07m, a $4.76m turnaround on the previous corresponding period (pcp) and 45% ahead of our forecast for underlying NPAT of $0.74m.
  • The result was struck on better-than-forecast revenue of $6.99m, the second-best half-year revenue result reported by the company in its history and an increase of 185% on the pcp.
  • Operating cash flow for the half increased 194% to $1.8m, the company’s best-ever half-year operating cash-flow result.

PointsBet (PBH AU) Rebuffs BlueBet And Enters Offer With Mixi (2121 JP)

By David Blennerhassett

  • PointsBet Holdings (PBH AU), an Australian/Canadian online wagering platform, has entered into a Scheme Implementation Deed with Mixi Inc (2121 JP).
  • Mixi is offering A$1.06/share, a 27.7% premium to last close and an implied EV/EBITDA of 25.2x-32.1x for FY25E. Apart from PointsBet’s shareholder approval, the Offer requires FIRB signing off.
  • Separately, Pointsbet’s key rival BlueBet Holdings (BBT AU) has tabled, what appears to be, a higher non-binding cash/scrip offer by way of Scheme, which PointsBet has allegedly ignored. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Perseus Mining, Iron Ore and more

By | Australia, Daily Briefs

In today’s briefing:

  • The Best Use of Capital in a Gold Bull Market (Jeff Quartermaine)
  • [IO Technicals Weekly 2025/08] IO Prices Extend Uptrend


The Best Use of Capital in a Gold Bull Market (Jeff Quartermaine)

By Money of Mine

  • Duck projects and operations, specializing in large-scale builds
  • Jeff Quartermain leads Perseus Mining, discussing Predictive stake and valuation
  • Emphasis on creating value and diversification in mining investments

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


[IO Technicals Weekly 2025/08] IO Prices Extend Uptrend

By Pranay Yadav

  • Iron ore futures rose USD 1.30/ton last week, closing at USD 107.25/ton, driven by China’s steel demand recovery and tighter supply from Australian cyclone disruptions.
  • Technical indicators show mixed signals, with prices above the 100-day & 200-day DMAs, but MACD weakening and RSI forming a death cross, suggesting potential bearishness ahead.
  • Financial Institutions and Managed Money increased net long positions, while Physicals participants expanded net shorts, reflecting diverging market expectations amid China’s policy-driven demand outlook.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Sg Fleet, Iron Ore, Bell Financial, Telix Pharmaceuticals and more

By | Australia, Daily Briefs

In today’s briefing:

  • SG Fleet (SGF AU): 8th April Scheme Vote
  • Fortescue Metals Group (FMG AU): The Thrill Is Gone, And So Has The Dividend
  • Bell Financial Group Ltd – Diversification continues to drive growth
  • Telix Pharmaceuticals (TLX AU): Record Performance in 2024; Robust Forecast for 2025


SG Fleet (SGF AU): 8th April Scheme Vote

By David Blennerhassett

  • On the 25 November 2024, SG Fleet (SGF AU) (SGF), an Aussie provider of fleet leasing services, announced a A$3.50/share non-binding/indicative proposal from Sydney PE outfit Pacific Equity Partners (PEP).
  • On the 4th December, both parties entered into a SID on the same terms. SGF’s largest shareholder, Super Group (SUPER SP) (53.58%), was supportive. 
  • The Scheme Booklet is now out, with a Scheme Meeting on the 8th April. Expected implementation on the 30th April. The IE (Grant Thornton) says fair & reasonable.

Fortescue Metals Group (FMG AU): The Thrill Is Gone, And So Has The Dividend

By Sameer Taneja

  • Fortescue Metals (FMG AU) announced disappointing results, with revenues/profits down 16%/53% YoY, disappointing consensus slightly by 4-5%. 
  • Capex accelerated to 3.5-3.8 bn USD annually, vs the initial 3.2-3.5 USD. The company reduced its decarbonization capex to 400-500 mn USD from the initial >700 mn USD. 
  • Fortescue Metals (FMG AU)  dividend payout ratio has reverted to its base level of 65%, yielding a modest 5.3% based on H1FY25’s 50-cent distribution.

Bell Financial Group Ltd – Diversification continues to drive growth

By Research as a Service (RaaS)

  • RaaS has published an update report on diversified financials company Bell Financial Group (ASX:BFG) following the release of its FY24 audited results which demonstrated H2 CY24 acceleration in NPAT relative to H1 in the key recurring revenue businesses of Technology & Platforms (+18% vs. +2%) and Products & Services (+9% vs. +3%) as scale benefits continue.
  • The Retail & Institutional business benefited from improved ECM activity and equity volumes, with H1 FY24 NPAT growth ~290% and H2 FY24 +6% off a strong base.
  • Products & Services delivered 10% NPAT growth in CY24, with H2 growth accelerating to 16% following 3% growth in H1 as scale benefits kicked in.

Telix Pharmaceuticals (TLX AU): Record Performance in 2024; Robust Forecast for 2025

By Tina Banerjee

  • Telix Pharmaceuticals (TLX AU) reported 2024 revenue of A$783M, up 56% YoY, beating full year revised guidance of A$745–776M, driven by Illuccix. 2024 R&D expenditure was in-line with guidance.
  • Telix provides 2025 revenue guidance of A$1.18–1.23B ($770–800M), up 51–57% YoY. The company expects 2025 R&D expenses to increase 20–25% YoY to A$234–243M.
  • 2025 will be a pivotal year for Telix, with three new products launches planned for this year in the U.S. (Zircaix, Pixclara, and Gozellix) and the European/UK rollout of Illuccix.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Mayne Pharma, Domain Holdings Australia , Sg Fleet and more

By | Australia, Daily Briefs

In today’s briefing:

  • Mayne Pharma (MYX AU): Cosette Pharma’s Binding Offer at A$7.40
  • Domain Holdings (DHG AU): CoStar Raids the Register and Launches a NBIO at A$4.20
  • SG Fleet (SGF AU): Scheme Vote on 8 April


Mayne Pharma (MYX AU): Cosette Pharma’s Binding Offer at A$7.40

By Arun George

  • Mayne Pharma (MYX AU) entered a scheme implementation deed with Cosette Pharma at A$7.40 per share, a 36.8% premium to the undisturbed price.
  • The offer is conditional on shareholder and FIRB approval. The vote is low-risk as the two largest shareholders are supportive.  
  • The offer is reasonable but not a knockout bid. At the last close and for an end-of-May payment, the gross/annualised spread was 2.8%/11.0%. 

Domain Holdings (DHG AU): CoStar Raids the Register and Launches a NBIO at A$4.20

By Arun George

  • Domain Holdings Australia (DHG AU) announced a non-binding proposal from Costar Group (CSGP US) at A$4.20, a 34.6% premium to the undisturbed price of A$3.12 (20 February).
  • The bid follows CoStar’s acquisition of a 16.9% stake in Domain on 20 February. Nine Entertainment Co Holdings (NEC AU)‘s support is crucial for its success.  
  • While attractive to precedent transaction multiples, the offer is light compared to peer multiples. Nine is evaluating the offer and will likely push for improved terms.

SG Fleet (SGF AU): Scheme Vote on 8 April

By Arun George

  • The Sg Fleet (SGF AU) IE considers Pacific Equity Partners’ A$3.50 offer fair and reasonable. 
  • The key conditions are shareholder (Super Group (SPG SJ) and SG Fleet) and regulatory (FIRB, OIO and FCA) approval. 
  • The offer is attractive compared to peer multiples and represents an all-time high. At the last close and for a 30 April payment, the gross/annualised spread is 1.5%/8.5%.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: REA Group Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • StubWorld: REA Group Dives As CoStar Muscles Into Turf


StubWorld: REA Group Dives As CoStar Muscles Into Turf

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Domain Holdings Australia , Mayne Pharma and more

By | Australia, Daily Briefs

In today’s briefing:

  • Domain Holdings (DHG AU): CoStar Makes an NBIO; Buys 16.9% Stake; Short Covering Today
  • Domain (DHG AU): CoStar’s A$4.20/Share NBIO
  • Mayne Pharma (MYX AU): Cosette’s A$7.40/Share Scheme


Domain Holdings (DHG AU): CoStar Makes an NBIO; Buys 16.9% Stake; Short Covering Today

By Brian Freitas


Domain (DHG AU): CoStar’s A$4.20/Share NBIO

By David Blennerhassett

  • Domain Holdings Australia (DHG AU), Australia’s  number two player in the online real estate market, has announced a non-binding proposal, by way of a Scheme, from CoStar Group (CSGP US).
  • CoStar is offering A$4.20/share, in cash. A A$0.02/share dividend declared on the 13th Feb will be added (but now ex). CoStar also acquired 16.9% of shares out, also at A$4.20/share.
  • Domain is 60% owned by Nine Entertainment Co Holdings (NEC AU), and has been known to be scoping out a buyer. A firm offer will require FIRB to sign off.

Mayne Pharma (MYX AU): Cosette’s A$7.40/Share Scheme

By David Blennerhassett

  • Mayne Pharma (MYX AU), a leader in dermatology and women’s health, has entered into a Scheme Implementation Deed with US-based pharmaceutical outfit, Cosette Pharmaceuticals.
  • Cosette is offering A$7.40/share, a 37% premium to last close. Apart from Mayne’s shareholder approval, the Offer requires FIRB signing off. 
  • The Offer also has the backing of Mayne’s two largest shareholder, Viburnum and Bruce Mathieson, collectively holding 14.1%. Implementation is expected late May, early June 2025. This is done.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars